Johnson & Johnson
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| JNJ.F | JNJ.NE | MRK | ZEG.F | LLY.NE | 4552.T | |
|---|---|---|---|---|---|---|
| Market cap | 593.52B | 915.54B | 370.96B | 259.78B | 1.74T | 64.55B |
| P/E (TTM) | 43.5 | 25.4 | 151.9 | 27.5 | 65.7 | — |
| Forward P/E | — | — | 16.7 | — | — | 14.4 |
| Price/book | 8.2 | 0.8 | 8.9 | 5.6 | 1.4 | 1.6 |
| Dividend yield | 2.00% | 2.49% | 2.26% | 1.68% | 0.58% | 3.97% |
| 1-year change | +47.99% | +40.84% | +75.29% | +16.72% | +35.37% | −17.24% |
| Today | −0.20% | +4.32% | +3.93% | −0.86% | +0.78% | +4.96% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All JNJ.F news ›Buy Max Healthcare; target of Rs 1200: Anand Rathi- Moneycontrol.com
Anand Rathi is bullish on Max Healthcare has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated November 03, 2026. Buy Max Healthcare; target of Rs 1200: Anand Rathi Anand Rathi's research…
Smith+Nephew cuts outlook after failed orthopaedics deal talks with J&J
Nov 4 (Reuters) - Smith+Nephew cut its full-year revenue and profit forecast on Wednesday as the British medical device maker also confirmed that talks about a potential merger with Johnson & Johnson's orthopaedics unit have ended. The…
More from 1 other outlet
JW Pharmaceutical Q3 Revenue Rises 6.3%, Profit Falls 10.7%
Korea's first economic newspaper, established in 1960. Providing comprehensive coverage of Korean business, finance, technology, and economic news. JW Pharmaceutical (001060.KS) posted a 6.3% rise in third-quarter revenue from a year…
Johnson Controls: 3 Key Takeaways for Long-Term Investors
Capital efficiency gains mean the company can expand production without a proportional increase in costs, a major operational advantage. Data center cooling requirements are accelerating as artificial intelligence facilities generate heavy…
A 4% Dividend Isn’t Always Worth More Than a 3% Tax-Free Bond Yield
A higher dividend yield sounds like a win, but taxes, Medicare surcharges, and bond mechanics can quietly flip the math against you before you collect your first payment. A municipal bond is a loan to a state, city, school district,…
The Dividend Portfolio That Covers Your Required Minimum Distribution Without Selling a Share: KMB, BIZD, and SPHD
Every December, retirees sell shares they would rather keep just to satisfy an IRS deadline they never asked for. A three-holding portfolio built around yield might change that math entirely, but only up to a certain age. Every December,…
Jim Cramer shares his favorite names in the life sciences space
CNBC Jim Cramer shares his favorite names in the life sciences space
4 Industrial Dividend Kings Whose Streaks Survived Every Recession
Industrial manufacturers face collapsing orders every time the economy stumbles, yet four companies have kept raising their dividends through every recession on record, and the secrets behind those streaks reveal something counterintuitive…
Law firm investigates Johnson & Johnson over Q3 earnings and revenue miss amid talc litigation costs.
Pomerantz LLP is investigating Johnson & Johnson for potential securities fraud following the company's Q3 2026 report showing net earnings of $210 million, heavily impacted by multi-billion dollar charges related to talc litigation…
Follow the Science, Follow the Money: What Q3 Reveals About Pharma Investment
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy. Enhance asset management with powerful tools that enable data-driven decisions and optimize your…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com140
- seekingalpha.com62
- defenseworld.net40
- themarketsdaily.com38
- 247wallst.com35
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.